Cortex Capital Management’s Global Cord Blood Corporation CO Stock Holding History

Cortex Capital Management’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-668,215	Closed	-$3.42M	–	20
2015 Q1	$3.42M	Sell	668,215 -127,142	-16%	-$625K	3.95%	10
2014 Q4	$3.6M	Buy	795,357 +44,458	+6%	+$211K	4.58%	10
2014 Q3	$3.67M	Sell	750,899 -100,000	-12%	-$485K	3.35%	12
2014 Q2	$4.7M	Sell	850,899 -130,000	-13%	-$584K	3.4%	12
2014 Q1	$3.92M	Buy	980,899 +40,000	+4%	+$163K	3.37%	11
2013 Q4	$3.77M	Buy	+940,899	New	+$3.75M	2.31%	13

Other funds holding CO

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cortex Capital Management's CO Position: Q2 2015 in Review

Cortex Capital Management sold out of Global Cord Blood Corporation (CO) in Q2 2015, closing a stake of 668,215 shares — an estimated $3.42M sold.

Cortex Capital Management first reported a position in CO in Q4 2013 and held it in 6 quarters. The position peaked at $4.7M in Q2 2014. 37 funds tracked by Wall St. Rank hold CO as of Q2 2015.

Cortex Capital Management reported no remaining Global Cord Blood Corporation position as of Q2 2015 after selling out during the quarter.
Cortex Capital Management sold 668,215 Global Cord Blood Corporation shares in Q2 2015, an estimated $3.42M.
Cortex Capital Management first reported a position in Global Cord Blood Corporation in Q4 2013 and held it in 6 quarters.
Cortex Capital Management's Global Cord Blood Corporation position peaked at $4.7M in Q2 2014.
37 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2015.

Based on Cortex Capital Management's 13F filing for Q2 2015.